The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma
Abstract
Immune checkpoint blockade has become a promising therapeutic approach to reverse immune cell exhaustion. Coinhibitory CD96 and T‐cell immunoglobulin and ITIM domain (TIGIT), together with costimulatory CD226, bind to common ligand CD155. The balancing between three receptors fine‐tunes immune responses against tumors. In this study, we investigated the expression of CD96, TIGIT, and CD226 in 55 fresh human hepatocellular carcinoma (HCC) samples, 236 paraffin‐embedded HCC samples, and 20 normal human livers. The cumulative percentage, absolute count, and mean fluorescence intensity (MFI) of CD96+ NK cells are significantly increased in the intratumoral tissues of HCC and break the balance between three receptors. Human CD96+ NK cells are functionally exhausted with impaired interferon‐gamma (IFN‐γ) and tumor necrosis factor‐alpha (TNF‐α) production, high gene expression of interleukin (IL)‐10 and transforming growth factor‐beta 1 (TGF‐β1), and low gene expression of T‐bet, IL‐15, perforin, and granzyme B. In addition, blocking CD96‐CD155 interaction specifically increases lysis of HepG2 cells by NK cells. HCC patients with a high level of CD96 or CD155 expression within tumor are strongly associated with deteriorating disease condition and shorter disease‐free survival (DFS) and overall survival times. Patients with a higher cumulative percentage of CD96+ NK cells within tumor also exhibit shorter DFS. High plasma level of TGF‐β1 in HCC patients up‐regulates CD96 expression and dynamically shifts the balance between CD96, TIGIT, and CD226 in NK cells. Blocking TGF‐β1 specifically restores normal CD96 expression and reverses the dysfunction of NK cells. Conclusion: These findings indicate that human intratumoral CD96+ NK cells are functionally exhausted and patients with higher intratumoral CD96 expression exhibit poorer clinical outcomes. Blocking CD96‐CD155 interaction or TGF‐β1 restores NK cell immunity against tumors by reversing NK cell exhaustion, suggesting a possible therapeutic role of CD96 in fighting liver cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yu, X., Harden, K., C Gonzalez, L., Francesco, M., Chiang, E., Irving, B., Tom, I., Ivelja, S., Refino, C. J., Clark, H., et al. (2009) · Nature Immunology · doi:10.1038/ni.1674 · Cited by 1,491
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
Johnston, R. J., Comps-Agrar, L., Hackney, J., Yu, X., Huseni, M., Yang, Y., Park, S., Javinal, V., Chiu, H., Irving, B., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.018 · Cited by 1,194
Liver immunology and its role in inflammation and homeostasis
Robinson, M. W., Harmon, C., & O’Farrelly, C. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.3 · Cited by 1,151
Zhang, Q., Bi, J., Zheng, X., Chen, Y., Wang, H., Wu, W., Wang, Z., Wu, Q., Peng, H., Wei, H., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0132-0 · Cited by 1,122
Self-citationTargeting natural killer cells in cancer immunotherapy
Guillerey, C., Huntington, N. D., & Smyth, M. J. (2016) · Nature Immunology · doi:10.1038/ni.3518 · Cited by 1,066
Hoechst, B., Voigtlaender, T., Ormandy, L., Gamrekelashvili, J., Zhao, F., Wedemeyer, H., Lehner, F., Manns, M. P., Greten, T. F., & Korangy, F. (2009) · Hepatology · doi:10.1002/hep.23054 · Cited by 643
DNAM-1, A Novel Adhesion Molecule Involved in the Cytolytic Function of T Lymphocytes
Shibuya, A., Campbell, D., Hannum, C., Yssel, H., Franz-Bacon, K., McClanahan, T., Kitamura, T., Nicholl, J., Sutherland, G. R., Lanier, L. L., et al. (1996) · Immunity · doi:10.1016/s1074-7613(00)70060-4 · Cited by 641
The immune score as a new possible approach for the classification of cancer
Galon, J., Pagès, F., Marincola, F. M., Thurin, M., Trinchieri, G., Fox, B. A., Gajewski, T. F., & Ascierto, P. A. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-1 · Cited by 628
The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
Chan, C. J., Martinet, L., Gilfillan, S., Souza-Fonseca-Guimaraes, F., Chow, M. T., Town, L., Ritchie, D. S., Colonna, M., Andrews, D. M., & Smyth, M. J. (2014) · Nature Immunology · doi:10.1038/ni.2850 · Cited by 492
Balancing natural killer cell activation through paired receptors
Martinet, L., & Smyth, M. J. (2015) · Nature Reviews Immunology · doi:10.1038/nri3799 · Cited by 485
TIGIT and CD 96: new checkpoint receptor targets for cancer immunotherapy
Dougall, W. C., Kurtulus, S., Smyth, M. J., & Anderson, A. C. (2017) · Immunological Reviews · doi:10.1111/imr.12518 · Cited by 435
Chew, V., Chen, J., Lee, D., Loh, E., Lee, J., Lim, K. H., Weber, A., Slankamenac, K., Poon, R. T. P., Yang, H., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300509 · Cited by 359
Fuchs, A., Cella, M., Giurisato, E., Shaw, A. S., & Colonna, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.3994 · Cited by 358
Cai, L., Zhang, Z., Zhou, L., Wang, H., Fu, J., Zhang, S., Shi, M., Zhang, H., Yang, Y., Wu, H., et al. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.08.012 · Cited by 288
Sun, C., Xu, J., Huang, Q., Huang, M., Wen, H., Zhang, C., Wang, J., Song, J., Zheng, M., Sun, H., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1264562 · Cited by 288
Self-citationCarlsten, M., Norell, H., Bryceson, Y. T., Poschke, I., Schedvins, K., Ljunggren, H.-G., Kiessling, R., & Malmberg, K.-J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901226 · Cited by 283
Wu, Y., Kuang, D.-M., Pan, W.-D., Wan, Y.-L., Lao, X.-M., Wang, D., Li, X.-F., & Zheng, L. (2013) · Hepatology · doi:10.1002/hep.26192 · Cited by 266
Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy
Blake, S. J., Stannard, K., Liu, J., Allen, S., Yong, M. C. R., Mittal, D., Aguilera, A. R., Miles, J. J., Lutzky, V. P., de Andrade, L. F., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0944 · Cited by 243
Molecular pathways: targeting CD96 and TIGIT for cancer immunotherapy
Blake, S. J., Dougall, W. C., Miles, J. J., Teng, M. W. L., & Smyth, M. J. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0933 · Cited by 223
Sun, C., Fu, B., Gao, Y., Liao, X., Sun, R., Tian, Z., & Wei, H. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002594 · Cited by 202
Self-citationNK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma
Sun, C., Sun, H., Zhang, C., & Tian, Z. (2015) · Cellular & Molecular Immunology · doi:10.1038/cmi.2014.91 · Cited by 200
Self-citationLiver natural killer cells: subsets and roles in liver immunity
Peng, H., Wisse, E., & Tian, Z. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.96 · Cited by 181
Self-citationZhang, Q.-F., Yin, W.-W., Xia, Y., Yi, Y.-Y., He, Q.-F., Wang, X., Ren, H., & Zhang, D.-Z. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.28 · Cited by 161
He, Y., Zheng, X., Sit, C. H. P., Loo, W. T., Wang, Z., Xie, T., Jia, B., Ye, Q., Tsui, K., Chow, L. W. C., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-s1-s12 · Cited by 157
Wang, P. L., O'Farrell, S., Clayberger, C., & Krensky, A. M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.8.2600 · Cited by 139
Toutirais, O., Cabillic, F., Friec, G. L., Salot, S., Loyer, P., Gallo, M. L., Desille, M., Pintière, C. T. D. L., Daniel, P., Bouet, F., et al. (2009) · European Journal of Immunology · doi:10.1002/eji.200838409 · Cited by 132
Adaptive immunity in the liver
Shuai, Z., Leung, M. W., He, X.-S., Zhang, W., Yang, G., Leung, P. S. C., & Gershwin, M. E. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.4 · Cited by 106
The murine pan T cell marker CD96 is an adhesion receptor for CD155 and nectin-1
Seth, S., Maier, M. K., Qiu, Q., Ravens, I., Kremmer, E., Förster, R., & Bernhardt, G. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.102 · Cited by 99
Kennedy, J., Vicari, A. P., Saylor, V., Zurawski, S., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., & Zlotnik, A. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.5.725 · Cited by 89
Sun, C., Xu, J., Song, J., Liu, C., Wang, J., Weng, C., Sun, H., Wei, H., Xiao, W., Sun, R., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5801 · Cited by 75
Self-citationBrooks, J., Fleischmann-Mundt, B., Woller, N., Niemann, J., Ribback, S., Peters, K., Demir, İ. E., Armbrecht, N., Ceyhan, G. O., Manns, M. P., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-2415 · Cited by 73
Liver-resident NK cells and their potential functions
Peng, H. C., & Sun, R. (2017) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.72 · Cited by 70
Self-citationPaired NK cell receptors controlling NK cytotoxicity
Stanietsky, N., & Mandelboim, O. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.08.047 · Cited by 64
T-Cell Ig and ITIM Domain Regulates Natural Killer Cell Activation in Murine Acute Viral Hepatitis
Bi, J., Zhang, Q., Liang, D., Xiong, L., Wei, H., Sun, R., & Tian, Z. (2013) · Hepatology · doi:10.1002/hep.26968 · Cited by 59
Self-citationHarjunpää, H., Blake, S. J., Ahern, E. S., Allen, S. M., Liu, J., Yan, J., Lutzky, V. P., Takeda, K., Aguilera, A. R., Guillerey, C., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1445949 · Cited by 52
Yu, M., & Li, Z. (2017) · Frontiers of Medicine · doi:10.1007/s11684-017-0546-3 · Cited by 39
Chávez‐González, A., Dorantes-Acosta, E. M., Moreno-Lorenzana, D., Alvarado‐Moreno, J. A., Arriaga‐Pizano, L., & Mayani, H. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.04.001 · Cited by 37
Gong, J., Zhu, C., Zhuang, R., Song, C., Li, Q., Xu, Z., Wei, Y., Yang, K., Yang, A., Chen, L., et al. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03829.x · Cited by 12
Cited by
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Bruni, D., Angell, H. K., & Galon, J. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0285-7 · Cited by 1,586
Exploring the NK cell platform for cancer immunotherapy
Myers, J. A., & Miller, J. S. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0426-7 · Cited by 1,276
Natural killer cells in cancer biology and therapy
Wu, S.-Y., Fu, T., Jiang, Y.-Z., & Shao, Z.-M. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01238-x · Cited by 863
The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma
Donne, R., & Lujambio, A. (2023) · Hepatology · doi:10.1002/hep.32740 · Cited by 631
Tumor Immunology and Tumor Evolution: Intertwined Histories
Galon, J., & Bruni, D. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.018 · Cited by 540
Metadata
- Authors
- Sun, H., Huang, Q., Huang, M., Wen, H., Lin, R., Zheng, M., Qu, K., Li, K., Wei, H., Xiao, W., Sun, R., Tian, Z., & Sun, C.
- Venue
- Hepatology
- Published
- 2019-03-05
- Volume
- 70
- Issue
- 1
- Pages
- 168-183
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W2899573186
- Cited by
- 300
- References
- 38
- FWCI
- 8.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.